Work

Supplementary Figure 6 from A p53/ARF-Dependent Anticancer Barrier Activates Senescence and Blocks Tumorigenesis without Impacting Apoptosis

Year: 2023

Type: supplementary-materials

Abstract: In contrast to premalignant lesions, ErbB2-initiated tumors in wildtype and ARF-null mammary glands exhibit comparable senescence and DDR.

DOI: 10.1158/1541-7786.22515048.v1

Authors: Vidya C. Sinha, Lan Qin, Yi Li

Language: English

Topic: Telomeres, Telomerase, and Senescence

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362536764

Cites:

Cited by:

Related to: 10